Moriarty B J, Acheson R W, Condon P I, Serjeant G R
Medical Research Council Laboratories, University of the West Indies, Kingston, Jamaica.
Eye (Lond). 1988;2 ( Pt 3):330-5. doi: 10.1038/eye.1988.62.
Ophthalmic assessments of 120 patients with homozygous sickle cell (SS) disease and of 222 with sickle cell haemoglobin-C (SC) disease were conducted over a period of ten years. Visual acuity loss (V.A. less than or equal to 6/18) attributable to sickle cell retinopathy occurred in 10% of untreated eyes during a mean observation period of 6.9 years. Visual loss was strongly associated with proliferative sickle retinopathy (p less than 0.001) and most commonly resulted from vitreous haemorrhage, tractional retinal detachment and epiretinal membranes. The incidence of visual loss was 31 per 1000 eye-years observation among eyes with proliferative disease compared to 1.4 per 1000 eye-years observation among eyes with non-proliferative disease.
在十年期间,对120例纯合子镰状细胞(SS)病患者和222例镰状细胞血红蛋白C(SC)病患者进行了眼科评估。在平均6.9年的观察期内,10%未经治疗的眼睛因镰状细胞视网膜病变出现视力丧失(视力小于或等于6/18)。视力丧失与增殖性镰状视网膜病变密切相关(p<0.001),最常见的原因是玻璃体积血、牵拉性视网膜脱离和视网膜前膜。增殖性疾病患者每1000眼年观察期的视力丧失发生率为31例,而非增殖性疾病患者每1000眼年观察期的发生率为1.4例。